Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 19Urogenital Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Prostatic Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasms 1Metastatic Castration-sensitive Prostate Cancer 1Genital Neoplasms, Male 1Carcinoma 1Adenocarcinoma 1

Interventions

padeliporfin 4motexafin gadolinium 2Sunitinib 2Radiotherapy 2Paclitaxel 2Genetic Testing 2Carboplatin 2vinflunine 1temsirolimus 1sipuleucel-T 1niraparib 1luprolide acetate gel depot 1apalutamide 1Tinzaparin 1Therapeutics 1Taste 1Surveys and Questionnaires 1Specimen Handling 1Sildenafil Citrate 1Remote Patient Monitoring 1Radiation Dose Hypofractionation 1Pemetrexed 1Ocoxin 1Neoadjuvant Therapy 1Leuprolide 1Immunotherapy 1Imatinib Mesylate 1Imagery, Psychotherapy 1Genetic Counseling 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Urogenital Neoplasms × luprolide acetate gel depot × Clear all
NCT01431391 2017-05-30

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Dendreon

Phase 2 Completed
68 enrolled 11 charts
Genitourinary

Adenocarcinoma, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡